Documents
Application Sponsors
ANDA 077022 | EPIC PHARMA LLC | |
Marketing Status
Discontinued | 001 |
Discontinued | 002 |
Application Products
001 | TABLET;ORAL | 100MG | 0 | CILOSTAZOL | CILOSTAZOL |
002 | TABLET;ORAL | 50MG | 0 | CILOSTAZOL | CILOSTAZOL |
FDA Submissions
| ORIG | 1 | AP | 2004-11-23 | |
LABELING; Labeling | SUPPL | 2 | AP | 2006-02-14 | |
LABELING; Labeling | SUPPL | 3 | AP | 2008-02-14 | |
LABELING; Labeling | SUPPL | 5 | AP | 2010-05-27 | |
LABELING; Labeling | SUPPL | 7 | AP | 2010-07-06 | |
LABELING; Labeling | SUPPL | 8 | AP | 2017-03-21 | STANDARD |
LABELING; Labeling | SUPPL | 9 | AP | 2020-11-18 | STANDARD |
Submissions Property Types
SUPPL | 5 | Null | 8 |
SUPPL | 7 | Null | 7 |
SUPPL | 8 | Null | 7 |
SUPPL | 9 | Null | 7 |
CDER Filings
EPIC PHARMA LLC
cder:Array
(
[0] => Array
(
[ApplNo] => 77022
[companyName] => EPIC PHARMA LLC
[docInserts] => ["",""]
[products] => [{"drugName":"CILOSTAZOL","activeIngredients":"CILOSTAZOL","strength":"100MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"CILOSTAZOL","submission":"CILOSTAZOL","actionType":"100MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)